End-of-day quote
Korea S.E.
23:00:00 22/05/2024 BST
|
5-day change
|
1st Jan Change
|
13,790
KRW
|
-1.22%
|
|
-7.01%
|
+294.00%
|
Fiscal Period: December |
2023
|
---|
Capitalization
1 |
34,879
|
Enterprise Value (EV)
1 |
-108,157
|
P/E ratio
|
0.39
x
|
Yield
|
57.1%
|
Capitalization / Revenue
|
0.1
x
|
EV / Revenue
|
-0.3
x
|
EV / EBITDA
|
-0.73
x
|
EV / FCF
|
-1.15
x
|
FCF Yield
|
-86.8%
|
Price to Book
|
0.15
x
|
Nbr of stocks (in thousands)
|
9,965
|
Reference price
2 |
3,500
|
Announcement Date
|
21/03/24
|
Fiscal Period: December |
2023
|
---|
Net sales
1 |
355,847
|
EBITDA
1 |
148,675
|
EBIT
1 |
142,339
|
Operating Margin
|
40%
|
Earnings before Tax (EBT)
1 |
152,435
|
Net income
1 |
116,436
|
Net margin
|
32.72%
|
EPS
2 |
8,921
|
Free Cash Flow
1 |
93,874
|
FCF margin
|
26.38%
|
FCF Conversion (EBITDA)
|
63.14%
|
FCF Conversion (Net income)
|
80.62%
|
Dividend per Share
2 |
2,000
|
Announcement Date
|
21/03/24
|
Fiscal Period: December |
2023
|
---|
Net Debt
1 |
-
|
Net Cash position
1 |
143,036
|
Leverage (Debt/EBITDA)
|
-
|
Free Cash Flow
1 |
93,874
|
ROE (net income / shareholders' equity)
|
47.3%
|
ROA (Net income/ Total Assets)
|
31.2%
|
Assets
1 |
372,839
|
Book Value Per Share
2 |
23,103
|
Cash Flow per Share
2 |
8,642
|
Capex
1 |
35,703
|
Capex / Sales
|
10.03%
|
Announcement Date
|
21/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +294.00% | 141M | | -4.17% | 12.11B | | -4.87% | 8.07B | | +5.36% | 5.67B | | +27.42% | 5.48B | | -9.89% | 4.12B | | -58.99% | 2.75B | | +8.97% | 2.62B | | -4.11% | 2.33B | | +21.58% | 2.11B |
Diagnostic & Testing Substances
|